These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 2812191

  • 1. [Bone and joint complications in patients treated with continuous ambulatory peritoneal dialysis (CAPD) for more than 3 years].
    Dratwa M, Wens R, Collart F, Tielemans C.
    Nephrologie; 1989; 10 Suppl():56-61. PubMed ID: 2812191
    [Abstract] [Full Text] [Related]

  • 2. [Renal osteodystrophy in dialysis patients as estimated by three-point bone densitometry].
    Kucharska E, Stompór T, Sułowicz W, Drozdz M, Kaczmarczyk I, Szymczakiewicz-Multanowska A, Chruściel B, Kraśnicka M.
    Przegl Lek; 2000; 57(6):334-9. PubMed ID: 11107868
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. Renal osteodystrophy in CAPD patients.
    Zucchelli P, Catizone L, Casanova S, Fusaroli M, Fabbri L, Ferrari G.
    Miner Electrolyte Metab; 1984 Nov; 10(5):326-32. PubMed ID: 6493161
    [Abstract] [Full Text] [Related]

  • 5. Bone mineral and aluminum concentrations in patients undergoing CAPD.
    Giangrande A, Costanini S, Ballanti P, Castiglioni A, Caligara F, Pisoni B, Giordano R, Vernillo I, Berni S, Bonucci E.
    Adv Perit Dial; 1992 Nov; 8():351-5. PubMed ID: 1361821
    [Abstract] [Full Text] [Related]

  • 6. [Renal osteodystrophy and growth in children undergoing CAPD].
    Ito T, Horiike S, Iitaka K.
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):779-90. PubMed ID: 1770638
    [Abstract] [Full Text] [Related]

  • 7. Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis.
    Aloni Y, Shany S, Chaimovitz C.
    Miner Electrolyte Metab; 1983 Aug; 9(2):82-6. PubMed ID: 6601753
    [Abstract] [Full Text] [Related]

  • 8. Effects of calcifediol treatment on the progression of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G, Bianchi ML, Valenti G, Lorenz M, Cresseri D.
    Nephron; 1990 Aug; 56(4):353-6. PubMed ID: 2079992
    [Abstract] [Full Text] [Related]

  • 9. Renal osteodystrophy and aluminum bone disease in CAPD patients.
    Gokal R.
    Clin Nephrol; 1988 Aug; 30 Suppl 1():S64-7. PubMed ID: 3052962
    [Abstract] [Full Text] [Related]

  • 10. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Aug; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 11. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G, Bianchi ML, Valenti G.
    Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771
    [Abstract] [Full Text] [Related]

  • 12. Differences in calcium kinetic pattern between CAPD and HD patients.
    Kurz P, Tsobanelis T, Roth P, Werner E, Ewald U, Grützmacher P, Schoeppe W, Vlachojannis J.
    Clin Nephrol; 1995 Oct; 44(4):255-61. PubMed ID: 8575126
    [Abstract] [Full Text] [Related]

  • 13. The role of DEXA bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patients.
    Johnson DW, McIntyre HD, Brown A, Freeman J, Rigby RJ.
    Perit Dial Int; 1996 Oct; 16(1):34-40. PubMed ID: 8616170
    [Abstract] [Full Text] [Related]

  • 14. Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.
    Hewitt IK, Stefanidis C, Reilly BJ, Kooh SW, Balfe JW.
    J Pediatr; 1983 Nov; 103(5):729-34. PubMed ID: 6631599
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis.
    Lin CY, Huang TP.
    Nephron; 1991 Nov; 59(1):90-5. PubMed ID: 1944754
    [Abstract] [Full Text] [Related]

  • 16. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.
    Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG.
    Kidney Int; 1994 Jan; 45(1):253-8. PubMed ID: 8127016
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low turnover bone disease is the more common form of bone disease in CAPD patients.
    Rodriguez-Perez JC, Plaza C, Torres A, Vega N, Anabitarte A, Fernandez A, Lorenzo V, Hortal L, Palop L.
    Adv Perit Dial; 1992 Jan; 8():376-80. PubMed ID: 1361827
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vitamin D therapy in CAPD: what is its role?
    Hutchison AJ, Gokal R.
    Adv Perit Dial; 1993 Jan; 9():253-6. PubMed ID: 8105937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.